Oncternal.png
Oncternal Therapeutics to Provide Business Update and Report Second Quarter 2024 Financial Results
August 01, 2024 16:05 ET | Oncternal Therapeutics
SAN DIEGO, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today...
logo-horizontal-main.png
Oncocyte to Announce Second Quarter 2024 Financial Results on August 8
August 01, 2024 16:05 ET | OncoCyte Corporation
Oncocyte to Announce Second Quarter 2024 Financial Results on August 8
X4-logo.png
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 01, 2024 16:05 ET | X4 Pharmaceuticals
BOSTON, Aug. 01, 2024 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced that, effective...
loco logo.png
El Pollo Loco Holdings, Inc. Announces Second Quarter 2024 Financial Results
August 01, 2024 16:05 ET | El Pollo Loco Holdings, Inc.
COSTA MESA, Calif., Aug. 01, 2024 (GLOBE NEWSWIRE) -- El Pollo Loco Holdings, Inc. (Nasdaq: LOCO) today announced financial results for the 13-week period ended June 26, 2024. Highlights for the...
Sun Country Logo.jpg
Sun Country Airlines Reports Second Quarter 2024 Results
August 01, 2024 16:05 ET | Sun Country Airlines
Sun Country Airlines Reports Second Quarter 2024 Results
ZimVie_Logo.png
ZimVie Reports Second Quarter 2024 Financial Results
August 01, 2024 16:05 ET | ZimVie Inc.
Third Party Net Sales from Continuing Operations of $116.8 millionNet Loss from Continuing Operations of $(9.6) million; Net Loss margin of (8.2%) Adjusted EBITDA[1] from Continuing Operations of...
SIGA logo blue.png
SIGA Reports Financial Results for Three and Six Months Ended June 30, 2024
August 01, 2024 16:05 ET | SIGA Technologies Inc.
Generated Product Sales of $21 Million in the Second Quarter, and $45 Million in the Six Months Ended June 30, 2024Received $113 Million Procurement Order from U.S. Government for Oral TPOXX in...
Lulus Logo.png
Lulus Releases Preliminary Second Quarter Results and Announces Second Quarter Earnings Call Date
August 01, 2024 16:05 ET | Lulu's Fashion Lounge Holdings, Inc.
CHICO, Calif., Aug. 01, 2024 (GLOBE NEWSWIRE) -- Lulu’s Fashion Lounge Holdings, Inc. (“Lulus” or the “Company”) (Nasdaq: LVLU) today announced preliminary unaudited financial results for the second...
SGHT Logo.png
Sight Sciences Reports Second Quarter 2024 Financial Results and Narrows Full Year 2024 Financial Guidance
August 01, 2024 16:05 ET | Sight Sciences, Inc.
MENLO PARK, Calif., Aug. 01, 2024 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) ("Sight Sciences" or the "Company"), an eyecare technology company focused on developing and commercializing...
Elutia Logo.jpg
Elutia Announces Full Exercise of Warrants Generating $15.7 Million in Gross Proceeds
August 01, 2024 16:05 ET | Elutia Inc.
SILVER SPRING, Md., Aug. 01, 2024 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix products, today announced that it had received gross...